Curative Biosciences Quick Ratio (BEVS) starting from the third quarter 2018 to third quarter 2017, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Curative Biosciences, Inc.  (BEVS)

Curative Biosciences's Quick Ratio

BEVS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2018, Quick Ratio fell to 0 below Curative Biosciences, Inc. average.

Within Nonalcoholic Beverages industry 30 other companies have achieved higher Quick Ratio than Curative Biosciences in third quarter 2018. While Quick Ratio total ranking has improved so far during the Q3 2018 to 5503, from total ranking in the second quarter 2017 at 5618.

Explain Quick Ratio?
How much Cash & cash equivalents BEVS´s has?
What are BEVS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BEVS Quick Ratio (Mar 31 2018)
Q3		 (Dec 31 2017)
Q2		 (Sep 30 2017)
Q1		 (Jun 30 2017)
Q4		 (Mar 31 2017)
Q3
Y / Y Current Liabilities Change 16.82 % 10.1 % 7.02 % 2.08 % 7.09 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 0 - - - -
BEVS's Total Ranking # 5503 # 5618 # 5591 # 4863 # 0
Seq. Current Liabilities Change 6.67 % 3.91 % 2.53 % 2.79 % 0.54 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio third quarter 2018 Company Ranking
Within: No.
Nonalcoholic Beverages Industry # 31
Consumer Non Cyclical Sector # 224
Overall Market # 5503


Quick Ratio Statistics
High Average Low
1.44 0.12 -0.01
(Sep 30 2011)   (Jun 30 2012)




Financial Statements
Curative Biosciences's Current Liabilities $ 1 Millions Visit BEVS's Balance sheet
Curative Biosciences's Cash & cash equivalent $ 0 Millions Visit BEVS's Balance sheet
Source of BEVS's Sales Visit BEVS's Sales by Geography


Cumulative Curative Biosciences's Quick Ratio

BEVS's Quick Ratio for the trailling 12 Months

BEVS Quick Ratio

 (Mar 31 2018)
12 Months		 (Dec 31 2017)
12 Months		 (Sep 30 2017)
12 Months		 (Jun 30 2017)
12 Months		 (Mar 31 2017)
12 Months
Y / Y Current Liabilities TTM Growth 9 % 6.55 % 5.74 % -0.5 % -4.32 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0 - - - -
Total Ranking TTM # 5405
Seq. Current Liabilities TTM Growth 4.03 % 2.47 % 1.73 % 0.53 % 1.69 %
Seq. Cash & cash equivalent TTM Growth - - - - -

Quick ratio ranking by company, industry and sector >> Back to BEVS Financial Strength Comparisons >> Go to Compare BEVS Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the unchanged in Current Liabilities in the Q3 2018 to $0.72 millions, cumulative Quick Ratio